Pharmacokinetic-Pharmacodynamic Interaction Between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 Mg/50 Mg Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects